Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
Critical Analysis: 10x Genomics (NASDAQ:TXG) & iRhythm Technologies (NASDAQ:IRTC)
02:16am, Saturday, 27'th Dec 2025
10x Genomics (NASDAQ: TXG - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two com
Assenagon Asset Management S.A. Invests $13.39 Million in iRhythm Technologies $IRTC
03:25am, Saturday, 20'th Dec 2025
Assenagon Asset Management S.A. bought a new stake in iRhythm Technologies (NASDAQ: IRTC) during the undefined quarter, according to the company in its most recent disclosure with the Securities and E
Frontier Capital Management Co. LLC Decreases Stock Position in iRhythm Technologies $IRTC
05:12am, Friday, 12'th Dec 2025
Frontier Capital Management Co. LLC trimmed its holdings in iRhythm Technologies (NASDAQ: IRTC) by 52.7% during the second quarter, according to the company in its most recent filing with the Securiti
Federated Hermes Inc. Invests $7.46 Million in iRhythm Technologies $IRTC
03:50am, Friday, 12'th Dec 2025
Federated Hermes Inc. acquired a new position in shares of iRhythm Technologies (NASDAQ: IRTC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. T
Head-To-Head Survey: Inspire Medical Systems (NYSE:INSP) versus iRhythm Technologies (NASDAQ:IRTC)
02:30am, Sunday, 07'th Dec 2025
iRhythm Technologies (NASDAQ: IRTC - Get Free Report) and Inspire Medical Systems (NYSE: INSP - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare t
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
02:25pm, Friday, 05'th Dec 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investig
iRhythm Technologies (NASDAQ:IRTC) Receives Average Rating of “Moderate Buy” from Brokerages
02:00am, Friday, 05'th Dec 2025
Shares of iRhythm Technologies (NASDAQ: IRTC - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fifteen research firms that are presently covering the company, Mark
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
03:53pm, Wednesday, 03'rd Dec 2025
iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
09:27am, Wednesday, 03'rd Dec 2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) b
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
03:18pm, Sunday, 30'th Nov 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is inve
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
09:41am, Monday, 17'th Nov 2025
NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) brea
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
09:15am, Wednesday, 12'th Nov 2025
New York, New York--(Newsfile Corp. - November 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NA
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies
New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.
